Vaginal Mesh Warnings

Vaginal mesh warnings were distributed to healthcare providers across the U.S. by the FDA in July 2011, and in September, the FDA held an advisory panel to further explore the risks and complications of vaginal mesh. The outcome of the advisory panel does not support the safety of vaginal mesh products.

FDA Warnings

Vaginal mesh is used as a surgical treatment for pelvic organ prolapse (POP) in which one or more internal organs have prolapsed (dropped) downward from their normal position. Vaginal mesh may also be used to treat stress urinary incontinence (SUI). Tens of thousands of women undergo vaginal mesh implant surgery each year in the U.S.

Vaginal mesh was approved as a surgical POP treatment in 2002, as a Class II device, which meant that preclinical trials were not required to test the safety of the the various brands and types of vaginal mesh. Now, the use of vaginal mesh is associated with thousands of reports of injuries and complications, described in the FDA's July Safety Communication. The complications include:

  • Infection, including recurrent urinary tract infections
  • vaginal mesh erosion (protrusion) into the vagina, bladder or rectum
  • organ perforation and bleeding
  • pelvic pain
  • dyspareunia (painful sex for a patient or her partner)
  • the need for additional corrective surgeries
  • urinary problems; e.g., difficulty urinating
  • vaginal scarring or shrinkage
  • recurrent prolapse
  • neuromuscular problems

Class III Reclassification Is Being Considered for Vaginal Mesh

The FDA advisory panel that convened in September 2011 called for additional clinical studies and tighter regulations for vaginal mesh. The panel's report suggested that preclinical use, premarket approval studies for new vaginal mesh products should be required, as opposed to the less stringent FDA device-clearance process that is now used for vaginal mesh. The panel also supports the reclassification of vaginal mesh products as Class III devices.

Learn More about the Risks of Vaginal Mesh

Whether you're a healthcare provider or a patient, if you have concerns about the complications and injuries linked to vaginal mesh, schedule a free consultation with a transvaginal mesh lawyer. Our lawyers represent women nationwide.

Transvaginal Mesh Litigation

Contact Us

Schedule a free and confidential case review today.

* is a required field

Attorney Advertising:
Flood Law Group, LLP
1101 Pennsylvania Avenue, Suite 600
Washington, DC 20004

Top News

Boston Scientific Faces Thousands of Vaginal Mesh Lawsuits

December 19th, 2013

As transvaginal mesh lawsuits against device maker Boston Scientific Corp. begin to move forward, the company has been directed to bring... read more

J&J Accused of Destroying Vaginal Mesh Documents

December 10th, 2013

As Johnson & Johnson gears up for the first federal vaginal mesh trial, the company faces allegations of destroying or misplacing... read more

Transvaginal Mesh Lawsuit against Boston Scientific to Begin in January 2015

December 4th, 2013

According to reports, a transvaginal mesh lawsuit filed on behalf of a woman who alleges injuries following surgery to correct pelvic... read more

Last Bellwether C.R. Bard Transvaginal Mesh Lawsuit Scheduled for Today

December 3rd, 2013

The latest C.R. Bard transvaginal mesh lawsuit is scheduled for today in the U.S. District Court in West Virginia. This lawsuit... read more

FDA Discusses Risk of Using of Surgical Mesh for POP

August 29th, 2011

The U.S. Food and Drug Administration (FDA) discusses the risks associated with use of transvaginal mesh.

"There are clear risks associated with... read more

Some Doctors Avoid Transvaginal Mesh to Treat POP

August 25th, 2011

In recent years, surgeons have used a device called surgical mesh to support the organs of a woman's pelvis that have... read more

Problems with POP Mesh Surgery Cause Clinical Trial to End Early

August 2nd, 2011

Complications with a medical device used to reinforce the vaginal wall for pelvic organ prolapse (POP) forced researchers to end a... read more